Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-20 Sale |
2025-03-24 9:21 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
750,000 | $10.92 | $8,190,725 | 21,577,447 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $10.65 | $1,065,000 | 11,812,158 (Direct) |
View |
| 2025-02-13 Sale |
2025-02-18 9:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
227,500 | $10.43 | $2,372,825 | 475,764 (Direct) |
View |
| 2025-02-12 Sale |
2025-02-14 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
435,425 | $10.47 | $4,561,041 | 23,249,337 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-22 9:04 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.28 | $1,128,000 | 12,358,528 (Direct) |
View |
| 2025-01-13 Purchase |
2025-01-15 4:36 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner |
16,845,010 | $20 | $336,900,200 | 96,650,341 (Direct) |
View |
| 2024-12-27 Sale |
2024-12-31 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
354,604 | $11.68 | $4,141,662 | 24,443,444 (Direct) |
View |
| 2024-12-23 Sale |
2024-12-26 9:00 pm |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
886,237 | $12.01 | $10,641,739 | 66,074,572 (Direct) |
View |
| 2024-12-20 Sale |
2024-12-26 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.49 | $1,149,000 | 12,821,814 (Direct) |
View |
| 2024-12-18 Sale |
2024-12-20 9:00 pm |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $12.05 | $4,971,637 | 34,947,147 (Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.32 | $1,132,000 | 12,932,759 (Direct) |
View |
| 2024-10-21 Sale |
2024-10-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $11.65 | $1,165,000 | 13,043,704 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-28 Tax Withholding |
2025-04-01 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,653 | $10.38 | 265,888 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 9:21 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
1,002,311 | $0 | 21,577,447 (Direct) |
View |
| 2025-03-20 Tax Withholding |
2025-03-24 9:21 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $10.97 | 21,577,447 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 9:21 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
1,002,311 | $3.85 | 21,577,447 (Direct) |
View |
| 2025-03-20 Option Award |
2025-03-24 9:01 pm |
N/A 2035-03-19 |
Roivant Sciences Ltd. | ROIV | Humes Jennifer Chief Accounting Officer |
227,363 | $0 | 227,363 (Direct) |
View |
| 2025-03-20 Tax Withholding |
2025-03-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,504 | $10.97 | 267,541 (Direct) |
View |
| 2025-03-20 Tax Withholding |
2025-03-24 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.97 | 17,305,656 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-04 9:11 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,635 | $10.74 | 269,045 (Direct) |
View |
| 2025-02-20 Tax Withholding |
2025-02-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
958 | $10.72 | 162,306 (Direct) |
View |
| 2025-02-20 Tax Withholding |
2025-02-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.72 | 17,316,601 (Direct) |
View |
| 2025-02-20 Exercise |
2025-02-24 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 11,812,158 (Direct) |
View |
| 2025-02-20 Exercise |
2025-02-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 11,812,158 (Direct) |
View |
| 2025-02-20 Tax Withholding |
2025-02-24 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $10.72 | 11,812,158 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
187,500 | $0 | 475,764 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
187,500 | $3.85 | 475,764 (Direct) |
View |
| 2025-02-12 Exercise |
2025-02-14 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
600,000 | $0 | 23,249,337 (Direct) |
View |
| 2025-02-12 Exercise |
2025-02-14 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
600,000 | $3.85 | 23,249,337 (Direct) |
View |
| 2025-01-28 Tax Withholding |
2025-01-30 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,896 | $11.15 | 270,680 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
1,672 | $0 | 39,529 (Direct) |
View |
| 2025-01-23 Tax Withholding |
2025-01-27 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
180 | $11.21 | 39,529 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
1,248 | $0 | 94,607 (Direct) |
View |
| 2025-01-23 Tax Withholding |
2025-01-27 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
306 | $11.21 | 94,607 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
2,386 | $0 | 99,929 (Direct) |
View |
| 2025-01-23 Tax Withholding |
2025-01-27 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
313 | $11.21 | 99,929 (Direct) |
View |
| 2025-01-23 Gift |
2025-01-27 11:40 am |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
13,357,857 | $0 | 53,431,427 (Direct) |
View |
| 2025-01-20 Tax Withholding |
2025-01-22 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,057 | $11.15 | 203,264 (Direct) |
View |
| 2025-01-21 Exercise |
2025-01-22 9:04 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 12,358,528 (Direct) |
View |
| 2025-01-20 Tax Withholding |
2025-01-22 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
8,682 | $11.15 | 12,358,528 (Direct) |
View |
| 2025-01-21 Exercise |
2025-01-22 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 12,358,528 (Direct) |
View |
| 2025-01-20 Tax Withholding |
2025-01-22 9:04 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,623 | $11.15 | 17,327,546 (Direct) |
View |
| 2024-12-28 Tax Withholding |
2024-12-31 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,896 | $11.8 | 272,576 (Direct) |
View |
| 2024-12-27 Exercise |
2024-12-31 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
500,000 | $0 | 24,443,444 (Direct) |
View |
| 2024-12-27 Exercise |
2024-12-31 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
500,000 | $3.85 | 24,443,444 (Direct) |
View |
| 2024-12-23 Exercise |
2024-12-26 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
886,237 | $0 | 66,074,572 (Direct) |
View |
| 2024-12-23 Exercise |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
886,237 | $3.85 | 66,074,572 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,129 | $11.57 | 274,472 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
3,087 | $11.57 | 204,321 (Direct) |
View |
| 2024-12-20 Exercise |
2024-12-26 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 12,821,814 (Direct) |
View |
| 2024-12-20 Exercise |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 12,821,814 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.57 | 12,821,814 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.57 | 17,339,169 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-20 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $0 | 34,947,147 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-20 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $3.85 | 34,947,147 (Direct) |
View |
| 2024-12-03 Other |
2024-12-05 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
3,651,985 | $12.21 | 22,488,532 (Direct) |
View |
| 2024-11-28 Tax Withholding |
2024-12-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,341 | $12.69 | 276,601 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
958 | $11.49 | 207,408 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-22 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 12,932,759 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 12,932,759 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.49 | 12,932,759 (Direct) |
View |
| 2024-11-20 Tax Withholding |
2024-11-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.49 | 17,350,114 (Direct) |
View |
| 2024-10-28 Tax Withholding |
2024-10-30 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,341 | $11.84 | 278,942 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
1,231 | $0 | 93,665 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
1,613 | $0 | 38,037 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
2,303 | $0 | 97,856 (Direct) |
View |
| 2024-10-21 Exercise |
2024-10-22 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $0 | 13,043,704 (Direct) |
View |
| 2024-10-21 Exercise |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
100,000 | $3.85 | 13,043,704 (Direct) |
View |
| 2024-10-20 Tax Withholding |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
10,945 | $11.92 | 13,043,704 (Direct) |
View |
| 2024-10-20 Tax Withholding |
2024-10-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
956 | $11.92 | 208,366 (Direct) |
View |